`

Gyroscope Therapeutics

Biotechnology Research

Specialities :
Gene therapy
Ophthalmology
Complement
And surgical device
revenue-icon Revenue
11M - 100M
funding-icon Total Funding
$60.0M
size-icon Size
11 - 50

Frequently Asked Questions About Gyroscope Therapeutics

What does Gyroscope therapeutics do?+

About Gyroscope Therapeutics, a Novartis company: Gyroscope Therapeutics is a clinical-stage gene therapy company developing gene therapy beyond rare disease to treat diseases of the eye that cause vision loss and blindness. The company was acquired by Novartis, a leading global medicines company, in February 2022. Gyroscopes lead investigational gene therapy, GT005, is currently being evaluated in Phase II clinical trials for the treatment of geographic atrophy (GA) secondary to age-related macular degeneration (AMD), a leading cause of blindness. GT005 has received Fast Track designation from the U.S. Food and Drug Administration for the treatment of people with GA. Guided...

What are Gyroscope therapeutics's specialties? +

Gene therapy,ophthalmology,complement,and surgical device

What is Gyroscope therapeutics's industry? +

Gyroscope therapeutics operates in the Biotechnology research industry.

What is Gyroscope therapeutics's revenue? +

Gyroscope therapeutics's revenue is 11m - 100m

What is Gyroscope therapeutics's company size? +

Gyroscope therapeutics has 11 - 50 employees.

The Go-to Sales Technology According to G2

G2 Badges Map
Get Started With Clodura
Sign Up

Sign Up for Free

Get Started with the Free Forever plan! No credit card needed. Enjoy up to 10,000 free email credits per month at no cost.

Supercharge Your Prospecting

Supercharge Your Prospecting

Start Prospecting from Clodura.AI's database of 600M+ verified B2B contacts and 120M+ direct dials along with 18M+ companies' org charts.

Grow Your Business

Grow Your Business

Unlock the prospect's contact details, including verified email, direct dials, add them to cadence, and close more deals.